| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.7326/0003-4819-124-12-199606150-00007 |
| P8608 | Fatcat ID | release_xhrzvb536ncfxffvxkz5bi34pa |
| P698 | PubMed publication ID | 8633821 |
| P2093 | author name string | Singh N | |
| Carrigan DR | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | emerging pathogen | Q108429945 |
| P304 | page(s) | 1065-1071 | |
| P577 | publication date | 1996-06-01 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | Human herpesvirus-6 in transplantation: an emerging pathogen | |
| P478 | volume | 124 |
| Q43702420 | (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assays showed a lack of toxicity of ganciclovir (GCV), C.OXTs, and their derivatives, to TaY(OK) cells at 1 microM. Therefore we compared the antiviral potencies of these drugs at 1 micr |
| Q37038492 | A complex interaction between drug allergy and viral infection |
| Q44495127 | American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation |
| Q46177065 | An assessment of herpesvirus co-infections in patients with CMV disease: correlation with clinical and virologic outcomes |
| Q33349234 | Anemia in children after transplantation: etiology and the effect of immunosuppressive therapy on erythropoiesis |
| Q40578590 | Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients |
| Q43743487 | Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients. |
| Q34918418 | Beta-herpesvirus challenges in the transplant recipient |
| Q73870643 | Correlation between the detection of viral DNA by the polymerase chain reaction in peripheral blood leukocytes and serological responses to human herpesvirus 6, human herpesvirus 7, and cytomegalovirus in renal allograft recipients |
| Q54547833 | Could a herpesvirus mimic tacrolimus-induced leukoencephalopathy? |
| Q34348068 | Critical care of the hematopoietic stem cell patient |
| Q74489912 | Current and potential therapies for the treatment of herpesvirus infections |
| Q44180781 | Detection of human herpesvirus 6 in patients with oral chronic graft-vs-host disease following allogeneic progenitor cell transplantation |
| Q44412730 | Detection of simultaneous β‐herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection |
| Q44438122 | Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry |
| Q40638537 | Differentiation and quantitation of human herpesviruses 6A, 6B and 7 by real-time PCR. |
| Q35196235 | Dominance of variant A in human herpesvirus 6 viraemia after renal transplantation |
| Q49135126 | Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter |
| Q36619721 | Emerging viral infections in transplantation |
| Q35804380 | Encephalitis owing to human herpesvirus-6 after cardiac transplant |
| Q40633205 | Encephalopathy associated with human herpesvirus 6 in a liver transplant recipient. |
| Q34271651 | Epidemiology of infections after solid-organ transplantation |
| Q42156606 | Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases |
| Q48573607 | Fatal HHV6 infection in an immunocompromised patient presenting with skin involvement |
| Q83050729 | Fatal hemophagocytic syndrome related to human herpesvirus-6 reinfection following liver transplantation: a case report |
| Q77386964 | Fine mapping of an apparently targeted latent human herpesvirus type 6 integration site in chromosome band 17p13.3. |
| Q33342189 | Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation |
| Q79716856 | HHV-6 DNA in peripheral blood mononuclear cells after liver transplantation |
| Q34632495 | HHV-8 infection in the transplantation setting: a concern only for solid organ transplant patients? |
| Q33383790 | Hematologic abnormalities following renal transplantation |
| Q34579836 | Herpesvirus infections in organ transplant recipients |
| Q45384781 | Human herpes virus 6 encephalomyelitis after bone marrow transplantation: report of an autopsy case |
| Q45747318 | Human herpes virus 6 fatal encephalitis in a bone marrow recipient |
| Q28142094 | Human herpesvirus 6 and multiple sclerosis: systemic active infections in patients with early disease |
| Q40613007 | Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients. |
| Q39549015 | Human herpesvirus 6 latently infects early bone marrow progenitors in vivo. |
| Q40461437 | Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients. |
| Q39594830 | Human herpesvirus 6 open reading frame U83 encodes a functional chemokine |
| Q42272326 | Human herpesvirus 6, 7 and 8 in solid organ transplantation |
| Q40548968 | Human herpesvirus type 6 and type 7 in transplant recipients |
| Q33816581 | Human herpesvirus-6 (HHV-6) and HHV-7 infections in bone marrow transplant recipients |
| Q34176585 | Human herpesvirus-6 and -7 in transplantation |
| Q53670674 | Human herpesvirus-6 as a possible cause of encephalitis and hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. |
| Q44608613 | Human herpesvirus-6 in renal transplant recipients: potential risk factors for the development of human herpesvirus-6 seroconversion. |
| Q40458531 | Human herpesvirus-6 infection in solid organ and stem cell transplant recipients. |
| Q36852379 | Identification of focal viral infections by confocal microscopy for subsequent ultrastructural analysis |
| Q33349222 | Imaging findings of paediatric oncology patients presenting with acute neurological symptoms. |
| Q33624126 | Incidence and risk factors for cytomegalovirus in kidney transplant patients in Babol, northern Iran |
| Q62618564 | Infección por herpesvirus humano-6 y trasplante de órganos |
| Q34294779 | Infection in solid organ transplantation. |
| Q38006193 | Infections caused by herpes viruses other than cytomegalovirus in solid organ transplant recipients. |
| Q73818592 | Infections in solid-organ transplant recipients |
| Q40531014 | Infections under immunosuppressive therapy following organ transplantation |
| Q34330062 | Infectious complications of lung transplantation |
| Q43038918 | Interactions between cytomegalovirus, human herpesvirus-6, and the recurrence of hepatitis C after liver transplantation |
| Q52132971 | Inverse relationship between human herpesvirus-6 and -7 detection after allogeneic and autologous stem cell transplantation. |
| Q42727723 | LightCycler-based quantitative PCR for rapid detection of human herpesvirus 6 DNA in clinical material |
| Q55317062 | MR imaging findings in some rare neurological complications of paediatric cancer. |
| Q37848137 | Monitoring and managing viral infections in pediatric renal transplant recipients |
| Q40264216 | New rising infection: human herpesvirus 6 is frequent in myeloma patients undergoing autologous stem cell transplantation after induction therapy with bortezomib |
| Q34481742 | Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts |
| Q52010634 | Persistent lack of human herpesvirus-6 specific T-helper cell response in liver transplant recipients. |
| Q53301048 | Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT |
| Q54782570 | Prevalence and clinical significance of human herpesviruses 6 and 7 active infection in pediatric liver transplant patients. |
| Q34294796 | Prevention of infections in solid organ transplant recipients |
| Q34191785 | Prophylaxis for CMV should now replace pre-emptive therapy in solid organ transplantation |
| Q44289627 | Recent Advances in the Management of Infections in Liver Transplant Recipients |
| Q28235605 | Reduction of adverse effects by a mushroom product, active hexose correlated compound (AHCC) in patients with advanced cancer during chemotherapy--the significance of the levels of HHV-6 DNA in saliva as a surrogate biomarker during chemotherapy |
| Q40326205 | Significance of herpesvirus 6 in BAL fluid of hematology patients with acute respiratory failure |
| Q46397669 | Successful treatment of an HHV6B-induced diarrhea with ganciclovir in a patient after PBSCT. |
| Q33782681 | Temporal mapping of transcripts in herpesvirus 6 variants. |
| Q39550084 | The U69 gene of human herpesvirus 6 encodes a protein kinase which can confer ganciclovir sensitivity to baculoviruses |
| Q34170307 | The current management of infectious diseases in the liver transplant recipient |
| Q34369538 | The expanding spectrum of herpesvirus infections of the nervous system |
| Q43761358 | The utility of plasma polymerase chain reaction for human herpes virus-6 among pediatric bone marrow transplant recipients: results of a pilot study |
| Q41361941 | Three new human herpesviruses (HHV6, 7, and 8). |
| Q77925237 | Transfusion of the HIV-seropositive patient: immunomodulation, viral reactivation, and limiting exposure to EBV (HHV-4), CMV (HHV-5), and HHV-6, 7, and 8 |
| Q37097708 | Viral infection after renal transplantation: surveillance and management |
| Q36401565 | Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies |
| Q34198401 | Viral infections after renal transplantation |
| Q79748079 | [Immunosuppression and infection in transplant recipients] |
| Q73483867 | [Isolation of human herpesvirus type 6 in the blood of patients receiving a renal transplant] |
Search more.